İbrahim GÖKÇE, Neslihan Çiçek DENİZ, Nurdan YILDIZ, Ülger ALTUNTAŞ, Harika ALPAY

Nefrolityazis tanısıyla başvuran bir olguda Dent hastalığı

Dent’s disease in a child with nephrolithiasis

PDF

___

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003; 63: 1817-23.
2. Dursun I, Poyrazoglu HM, Dusunsel R, et al. Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 2008; 40: 3-9.
3. Spivacow FR, Negri AL, del Valle EE, Calviño I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-33.
4. Scheinman SJ. Nephrolithiasis. Semin Nephrol 1999; 19: 381-8.
5. Alpay H, Ozen A, Gokce I, Biyikli N. Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009; 24: 2203-9.
6. Kroovand RL. Pediatric urolithiasis. Urol Clin North Am 1997; 24: 173-84.
7. Stechman MJ, Loh NY, Thakker RV. Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 2009; 24: 2321-32.
8. Claverie-Martín F Ramos-Trujillo E, García-Nieto V. Dent’s disease: clinical features and molecular basis. Pediatr Nephrol 2011; 26: 693-704.
9. Lloyd SE, Pearce SH, Fisher SE, et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996; 379: 445-9.
10. Hoopes RR Jr, Shrimpton AE, Knohl SJ, et al. Dent disease with mutations in OCRL1. Am J Hum Genet 2005; 76: 260-7.
11. Sarıca K. Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 2006; 34: 96-101.
12. Tosetto E, Ghiggeri GM, Emma F et al. Phenotypic and genetic heterogeneity in Dent’s disease--the results of an Italian collaborative study. Nephrol Dial Transplant 2006; 21: 2452-63.
13. Reinhart SC, Norden AG, Lapsley M, et al. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 1995; 5: 1451-61.